Q1 2021 Holdings
Filed 2021-05-13 | 166 holdings | $7.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| AbbVie Inc.(ABBV) | Common | 00287Y109 | $2.7M | 24,769 | 34.9% |
| Aurinia Pharmaceuticals Inc.(AUPH) | Common | 05156V102 | $2.0M | 154,840 | 26.2% |
| Coherus Biosciences, Inc.(CHRS) | Common | 19249H103 | $1.5M | 99,655 | 19.0% |
| Corteva Inc.(CTVA) | Common | 22052L104 | $561.0K | 12,033 | 7.3% |
| BioCryst Pharmaceuticals, Inc.(BCRX) | Common | 09058V103 | $312.0K | 30,703 | 4.1% |
| Butterfly Network, Inc.(BFLY) | Common | 124155102 | $309.0K | 18,380 | 4.0% |
| Cousins Properties(CUZ) | Common | 222795502 | $119.0K | 3,357 | 1.6% |
| Calumet Specialty Products Partners, LP | Common | 131476103 | $17.4K | 2,845,000 | 0.2% |
| Upland Software, Inc.(UPLD) | Common | 91544A109 | $14.2K | 300,000 | 0.2% |
| Apollo Global Management, Inc.(APOEUR) | Common | 03768E105 | $14.1K | 300,000 | 0.2% |
| Fortress Trans & Infrastructure Inv. LLC | Common | 34960P101 | $14.1K | 500,000 | 0.2% |
| Alphabet Inc(GOOG) | Common | 02079K107 | $11.6K | 5,600 | 0.2% |
| Ligand Pharmaceuticals Incorporated(LGND) | Common | 53220K504 | $11.4K | 75,000 | 0.1% |
| FS KKR Capital Corp.(FSK) | Common | 302635206 | $7.8K | 395,175 | 0.1% |
| Danimer Scientific, Inc. | Common | 236272100 | $7.6K | 200,000 | 0.1% |
| Midwest Holding Inc. | Common | 59833J206 | $7.5K | 150,000 | 0.1% |
| African Gold Acquistion Corp. | Common | G0112R116 | $6.1K | 618,000 | 0.1% |
| Twelve Seas Investment Company II | Common | 90118T205 | $5.1K | 515,000 | 0.1% |
| Glass Houses Acquisition Corp. | Common | 37714P202 | $5.0K | 500,000 | 0.1% |
| KKR & Co. Inc.(KKR) | Common | 48251W104 | $4.9K | 100,000 | 0.1% |
| Pfizer Inc.(PFE) | Common | 717081103 | $4.3K | 119,900 | 0.1% |
| Kennedy-Wilson Holdings, Inc.(KW) | Common | 489398107 | $4.2K | 210,000 | 0.1% |
| Eastern Bankshares Inc(EBC) | Common | 27627N105 | $3.9K | 200,000 | 0.1% |
| Horizon Therapeutics Public Ltd. Company | Common | G46188101 | $3.7K | 40,614 | 0.0% |
| Live Oak Mobility Aquisition Corp. | Common | 538126202 | $3.6K | 360,152 | 0.0% |
| Gilead Sciences, Inc.(GILD) | Common | 375558103 | $3.3K | 50,942 | 0.0% |
| Bristol-Myers Squibb Company(BMY) | Common | 110122108 | $3.2K | 51,409 | 0.0% |
| Kadmon Holdings, Inc.(KDMN) | Common | 48283N106 | $3.0K | 762,000 | 0.0% |
| Xenon Pharmaceuticals Inc.(XENE) | Common | 98420N105 | $2.6K | 144,101 | 0.0% |
| Kairos Acquisition Corp. | Common | G52110114 | $2.5K | 261,374 | 0.0% |
| Capitol Investment Corp. V | Common | 14064F100 | $2.5K | 250,000 | 0.0% |
| TG Therapeutics, Inc.(TGTX) | Common | 88322Q108 | $2.5K | 51,973 | 0.0% |
| Avadel Pharmaceuticals plc | Common | 05337M104 | $2.5K | 272,845 | 0.0% |
| Eiger BioPharmaceuticals, Inc.(CLDNEUR) | Common | 28249U105 | $2.4K | 276,535 | 0.0% |
| United Therapeutics Corporation(UTHR) | Common | 91307C102 | $2.4K | 14,500 | 0.0% |
| JP Morgan Chase(JPM) | Common | 46625H100 | $2.4K | 15,470 | 0.0% |
| Zogenix, Inc. | Common | 98978L204 | $2.3K | 117,688 | 0.0% |
| Trillium Therapeutics Inc. | Common | 89620X506 | $2.1K | 198,699 | 0.0% |
| Horizon Aquistion Corporation | Common | G46049105 | $2.1K | 210,100 | 0.0% |
| AllianceBernstein Holdings PL Unit Ltd(AB) | Common | 01881G106 | $2.0K | 50,500 | 0.0% |
| Constellation Pharmaceuticals, Inc.(CNST) | Common | 210373106 | $2.0K | 85,909 | 0.0% |
| Medicus Science Acquisition, Corp. | Common | G5960S116 | $2.0K | 200,000 | 0.0% |
| Tastemaker Acquisition Corp. | Common | 876545104 | $1.9K | 200,000 | 0.0% |
| B. Riley Principal 150 Merger Corp. | Common | 05601V202 | $1.8K | 175,963 | 0.0% |
| International Gaming Technologies(BRSL) | Common | G4863A108 | $1.7K | 107,500 | 0.0% |
| Kairos Acquisition Corp. Warrants | Common | G52110106 | $1.5K | 130,687 | 0.0% |
| Aslan Pharmaceuticals Limited | Common | 04522R101 | $1.5K | 437,412 | 0.0% |
| uniQure N.V.(QURE) | Common | N90064101 | $1.4K | 41,766 | 0.0% |
| Viking Therapeutics, Inc.(VKTX) | Common | 92686J106 | $1.3K | 208,102 | 0.0% |
| Verrica Pharmaceuticals, Inc. | Common | 92511W108 | $1.2K | 78,424 | 0.0% |